CNS Pharmaceuticals, Inc. (CNSP)
NASDAQ: CNSP · Real-Time Price · USD
2.890
-0.730 (-20.17%)
At close: Nov 13, 2026, 4:00 PM EST
3.100
+0.210 (7.27%)
After-hours: Nov 13, 2026, 4:10 PM EST
CNS Pharmaceuticals Employees
CNS Pharmaceuticals had 8 employees as of December 31, 2025. The number of employees increased by 3 or 60.00% compared to the previous year. That makes CNS Pharmaceuticals the 40,768th largest employer in the world and 6,159th in the United States.
Employees
8
Change (1Y)
3
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$2,087,446
Market Cap
4.22M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 8 | 3 | 60.00% | 8 | 0 |
| Dec 31, 2024 | 5 | 0 | - | 4 | 1 |
| Dec 31, 2023 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2022 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2021 | 5 | 0 | - | 3 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| Cerenome | 28 |
| Cardio Diagnostics Holdings | 17 |
| Lantern Pharma | 16 |
| Processa Pharmaceuticals | 12 |
| Aprea Therapeutics | 8 |
| XTL Biopharmaceuticals | 5 |
| Cadrenal Therapeutics | 5 |
CNSP News
- 2 months ago - CNS Pharmaceuticals details business development strategy - TheFly
- 2 months ago - CNS Pharmaceuticals Details Business Development Strategy Driving Its Next Phase of Growth - Accesswire
- 2 months ago - CNS Pharmaceuticals Participates in the Virtual Investor "Why Now" On-Demand Conference - Accesswire
- 2 months ago - CNS Pharmaceuticals Proxy statement: Proxy filing - Filings
- 2 months ago - CNS Pharmaceuticals Proxy statement: Proxy filing - Filings
- 2 months ago - CNS Pharmaceuticals Slides: Investor presentation - Filings
- 2 months ago - CNS Pharmaceuticals reports Q2 EPS (37c) vs. ($6.42) last year - TheFly
- 2 months ago - CNS Pharmaceuticals ‘actively evaluating’ business devlopment opportunities - TheFly